升主动脉No—touch技术在冠心病手术中的应用

目的探讨和评价升主动脉不接触技术（No—touch）在冠状动脉旁路移植手术中的应用。方法回顾5例合并升主动脉粥样硬化冠心病患者的临床资料,男3例,女2例,年龄68--76岁,平均70．2岁。5例均采用常规胸骨正中切口行非体外循环下冠脉搭桥（OPCABG）。2例行双侧乳内动脉原位移植,3例以左乳内动脉为唯一的供血来源,大隐静脉近端与左乳内动脉端侧吻合。所有患者未在升主动脉上进行任何操作。结果5例患者共移植血管13支,全组手术均顺利完成,痊愈出院,无院内死亡。手术后所有忠者心绞痛均消失,心功能改善I～II级。无围术期心肌梗死和神经系统并发症发生。结论对合并升主动脉粥样硬化的冠心病患者,采用OPCABG结合升主动脉不接触（No—touch）技术,可使病变冠脉完全再血管化,降低术后脑卒中的发生率,临床效果满意。     

Initial experience with sequential internal mammary artery bypass grafts to the left anterior descending and left anterior descending diagonal coronary arteries

Early patency and late patency have consistently been better with single internal mammary artery grafts than with saphenous vein conduits. To determine the efficacy of these two types of grafts in sequential anastomoses, we performed sequential anastomoses of the left internal mammary artery to the left anterior descending and diagonal coronary arteries in 40 patients and compared the results with those in 58 patients who received sequential saphenous vein grafts. Treatment with dipyridamole (starting 48 hours before operation) and aspirin (added 7 hours after operation) was given to the 40 patients with internal mammary artery grafts and to 32 of the 58 patients in the saphenous vein group. After the bypass procedure, mean blood flows were as follows: 68 ml/min in patients with internal mammary artery grafts, 73 ml/min in patients who received saphenous vein grafts and a placebo, and 99 ml/min in those who received saphenous vein grafts, aspirin, and dipyridamole. Early patency of sequential internal mammary artery grafts to the diagonal and left anterior descending coronary arteries was comparable to that of sequential saphenous vein grafts. Because a substantial late reduction in patency has been noted in sequential saphenous vein grafts, sequential internal mammary artery grafts may be the preferred conduit for coronary artery revascularization.     

Use of the internal mammary artery for myocardial revascularization in a patient with radiation-induced coronary artery disease.

A 9-year-old boy with clinical stage IIA Hodgkin's disease underwent radiotherapy to the neck and mediastinum. Twenty-two years later, he sought medical attention because of angina pectoris. Cardiac catheterization revealed proximally located high-grade stenoses of the left main, left anterior descending, circumflex, and right coronary arteries. He underwent coronary artery bypass grafting with use of the left internal mammary artery to the left anterior descending coronary artery and reversed saphenous vein grafts to the circumflex and right coronary arteries. The postoperative course was uncomplicated. Previous radiotherapy to the mediastinum should be considered a risk factor for the development of premature coronary artery disease. Surgical revascularization is the preferred method of management. A combination of an internal mammary artery graft and a saphenous vein graft should be used in young patients.     

Reoperative off-pump coronary artery bypass grafting: current outcomes,concerns and controversies

Increasing numbers of patients have undergone coronary artery bypass grafting in the last four decades. As a result, the incidence of reoperative coronary artery bypass grafting is rising. Reoperative procedures pose several technical difficulties and are associated with increased operative risks, which exceed those of the initial revascularization. As the incidence of reoperative procedures is increasing so is the experience of reoperative coronary artery bypass grafting, with the resultant evolution of several alternative strategies to lower the operative risks. These strategies include alternative techniques for re-entry, strict avoidance of graft manipulation to minimize the risk of graft atheroembolism, and modification of the method of myocardial protection, depending on the status of the native coronary circulation and the patency of venous or arterial grafts. Off-pump coronary artery bypass grafting is one such technique that, through the avoidance of inherent risks of cardiopulmonary bypass, has the potential to reduce the morbidity associated with reoperative coronary artery bypass grafting. This article evaluates the current outcomes of reoperative off-pump coronary artery bypass grafting, and highlights the concerns and controversies associated with this strategy.     

Angioplasty for aortocoronary bypass graft stenosis

During the period November 1979 to October 1984, 19 patients at our institution underwent balloon angioplasty of partial or complete obstruction of aortocoronary artery saphenous vein bypass grafts. The procedures were performed a mean of 38 months after a coronary bypass operation to relieve recurrent angina of at least class 2 in the Canadian Cardiovascular Association functional classification. Graft angioplasty was successful in 16 of the 19 patients, and the location of the lesion (in the origin, body, or distal insertion of the graft) did not seem to be an important factor in achieving a successful result. At a mean follow-up interval of 20 months (range, 1 to 40 months), 14 patients had symptomatic improvement. Two patients required late repeat operation and four had repeat angioplasty because of restenosis. Our experience supports the use of balloon angioplasty in selected patients with bypass graft stenosis, but restenosis remains a substantial problem.     

Choosing a revascularization strategy for your patient with CAD. Consider both the clinical presentation and the urgency of the situation

For patients with less severe coronary artery disease, particularly one- or two-vessel disease, initial therapy may be with either thrombolytics or angioplasty. In those with more extensive disease (three-vessel or left main artery disease or proximal left anterior descending artery stenosis), bypass grafting can significantly reduce mortality. However, a patient's risk profile markedly influences outcome regardless of the procedure performed. Because angioplasty achieves incomplete revascularization, patients may need repeated angiography or revascularization, or they may have recurrent angina. If bypass graft disease is prevented, surgery may be effective for up to 20 years.     

Development of arterial revascularization of the myocardium at the Linz general hospital. Personal experiences with 1000 patients]

Arterial revascularization of the myocardium, particularly the use of the internal mammary artery (IMA) as a bypass graft in coronary artery surgery has become an established procedure over the past decade. From March 1986 to June 1991, of 2070 patients who underwent coronary heart surgery at our department, revascularization of the myocardium was performed with an IMA graft in 1000 cases, whereby the percentage increased from 10.4% in 1986 to 75.0% in 1991 (p less than 0.01). The range of indications gradually widened throughout the period, age no longer being a contradiction today. One reason for this development is the substantial improvement in IMA preparation technique. No increase was found in rethoracotomy rate or in the rate of perioperative infarctions. The mean age of patients receiving an IMA graft increased from 55.2 years (1986) to 64.7 years (1991) and therefore reflects the change in ranges of indication. 54 IMA jump grafts were anastomosed, in 30 cases bilateral IMAs were used and the IMA was implanted as a free graft twice. In the future these successful results with the implementation of IMA grafts will lead to a further displacement of the saphenous vein as main bypass material.     

Multicenter radial artery patency study (RAPS). Study design

The use of an internal thoracic artery rather than a saphenous vein graft for left anterior descending coronary artery bypass is associated with improved long-term outcome. Hence, expanded use of arterial conduits for other coronary targets has been advocated. The radial artery possesses a number of anatomic features that are technically advantageous compared with other arterial conduits. This study will determine the relative patency of the radial artery compared to the saphenous vein for right and circumflex coronary bypass. Patients with graftable multivessel coronary disease and an estimated left ventricular ejection fraction >/= 35% undergoing nonemergent primary isolated coronary bypass surgery are eligible. The right and circumflex vessels must have high-grade lesions (>/= 70% diameter stenosis), with target segments of reasonable quality >/= 1.5 mm in diameter. Patients serve as their own controls. The radial artery is randomly allocated to bypass the right or circumflex territory and a saphenous vein is used for the nonradial site. An internal thoracic artery is used for the left anterior descending coronary artery in all cases. Randomization is stratified by center. The primary study endpoint is graft patency as determined by angiography, 8-12 months postoperatively. The relative patency of the radial artery compared with the saphenous vein will be determined using McNemar's test. A sample size of 464 patients will provide 80% power for a two-tailed test (alpha = 0.05) for a 40% relative reduction in the rate of distal anastomotic occlusion from 12% in the saphenous vein to 7.2% in the radial arteries assuming a 20% within-patient correlation. A single interim analysis will be performed following completion of 232 angiograms. To allow for lack of follow-up angiography in up to 20% of enrolled patients, we plan to randomize a total of 560 patients. It is also our intention to assess the long-term patency (5-10 years) of radial artery relative to saphenous vein grafts in follow-up studies. Three hundred patients were recruited from 12 Canadian, university-affiliated sites from November 1996 until February 1999, of which 128 patients have undergone follow-up angiography. Approximately 80% of those who have been followed for more than 1 year have undergone follow-up angiography. This trial will determine the 8-12 month patency of the radial artery relative to the saphenous vein for non-left anterior descending coronary bypass using a novel study design which helps control for potential bias from individual patient and vessel factors. Positive results would support the use of the radial artery in particular, and multiple arterial grafts in general.     

CT血管造影分析体外循环与非体外循环冠状动脉旁路移植后的桥血管通畅率

背景：近年来,非体外循环冠状动脉旁路移植后桥血管通畅率是否与传统的体外循环冠状动脉旁路移植相同存在争议。目的：探讨体外循环与非体外循环冠状动脉旁路移植后桥血管时间通畅率的差异性。方法：选取同一操作者行体外循环冠状动脉旁路移植患者100例,按其临床特征及桥血管病变危险因素匹配抽取非体外循环冠状动脉旁路移植患者137例。采用64排多螺旋CT血管造影分析冠脉搭桥后1个月,1年,2年,3年,4年的桥血管通畅情况。结果与结论：共对641条桥血管进行评价,两组中左侧乳内动脉桥血管时间通畅率均高于大隐静脉桥,两组左侧乳内动脉桥和大隐静脉桥血管时间通畅率比较差异均无显著性意义。说明非体外循环与体外循环冠状动脉旁路移植后患者桥血管时间通畅率相似,对于某些适当的患者来说,非体外循环冠状动脉旁路移植不失为一个良好的选择。     

The technique of percutaneous transluminal coronary angioplasty. Uses, abuses, training requirements, benefits, complications

Like coronary artery bypass grafting, PTCA is used to manage multilesion and multivessel disease, new complete occlusions, and partial occlusions of saphenous vein or internal mammary artery grafts. PTCA is contraindicated for patients with a significant obstructive lesion in the left main coronary artery or with severe diffuse atherosclerosis. In determining whether this procedure provides the best treatment option, the risk of abrupt vessel closure, restenosis, MI, or incomplete revascularization must be considered. Guidelines for the performance of PTCA and physician and institutional responsibilities have been established; these guidelines must be regarded as necessary criteria for wide adoption.     

双源CT对冠状动脉桥血管的评价

【目的】评价双源螺旋CT对冠脉搭桥术后桥血管开通的诊断价值。【方法】对57例冠状动脉搭桥术后的患者行双源螺旋CT冠状动脉成像检查。【结果】所有141支桥血管均重建成功。其中内乳动脉桥39支,大隐静脉桥102支,通畅的桥血管102支（72．3％）,不同程度狭窄15支（10．63％）,完全闭塞24支（17．02％）。39支内乳动脉桥支33支通畅（84．62％）,102支大隐静脉桥支69支通畅（67．65％）,两种桥血管间相比较差异显著（P〈0．05）。【结论】双源螺旋CT是评价冠状动脉搭桥术后桥血管开通的有价值的无创检查方法。     

Mammary-coronary artery anastomosis for myocardial revascularization

My experience with the use of mammary-coronary artery anastomosis for myocardial revascularization in 1,500 patients over a nine-year period has been described. The procedure was used in approximately 85% of patients undergoing coronary bypass surgery, but mammary arteries accounted for only one third of the grafts. Patency rates as determined by arteriography performed from two weeks to seven years after operation were more than 95%. No late alterations in the mammary artery grafts have been seen. Clinical results have been so gratifying that I regard the procedure as the one of choice for bypass of stenosis of the left anterior descending coronary artery.     

Assessment of coronary artery bypass graft patency by multidetector computed tomography and electron-beam tomography

This case report describes the use of retrospectively ECG-gated 16-slice multidetector computed tomography (MDCT) and electron-beam tomography (EBT) for assessing bypass graft patency in two patients with recurrent angina after coronary artery bypass graft surgery. The results of each tomographic modality were compared to the findings of traditional coronary angiography. In the first patient MDCT showed occlusion of the left internal mammary artery (LIMA) and saphenous vein graft after the second anastomosis. Coronary angiography confirmed these findings. In the second patient EBT showed patency of the LIMA and saphenous vein graft. After the first anastomosis of the saphenous vein graft, the connected vessel filled poorly. Coronary angiography confirmed both grafts to be patent, and detected an occlusion distal to the first anastomosis. These findings support the evidence that both MDCT and EBT are suitable techniques for establishing bypass graft patency by non-invasive means.     

心脏镜多支冠状动脉搭桥术的动物实验研究

目的探讨心脏镜即不需辅助小切口的完全内镜下多支冠状动脉搭桥术术式的可行性。方法实验动物为2头猪和24条狗,胸壁打孔,进行多支冠状动脉搭桥手术的操作。结果经过1.5cm的3、4个小孔可以完成右冠状动脉、左冠状动脉、前降支、对角支及回旋支等多支冠状动脉的搭桥手术,并能顺利完成左锁骨下动脉、降主动脉的远端吻合口的吻合操作。结论心脏镜多支冠状动脉搭桥术切实可行,值得进一步研究。不久的将来有可能成为心脏搭桥术的主要术式。     

冠脉搭桥术后桥管的超声检查方法研究

目的探讨经胸超声检查冠脉搭桥术后桥管的显像方法及血流状态。方法采用经胸超声冠脉血流显像与高频血管显像相结合对左乳内动脉原位转流至左前降支、大隐静脉-右冠状动脉及大隐静脉-左回旋支桥管进行检查。结果左乳内动脉桥管、大隐静脉-右冠状动脉及大隐静脉-左回旋支桥管显示率分别为100%、93.75%和20%。左乳内动脉及大隐静脉桥管的血流均为舒张期为主的双期血流;左乳内动脉桥管的舒张期血流速度及流速时间积分大于大隐静脉桥管（P〈0.05）。结论经胸超声是术后桥管检查的较好方法,可用于无创的评估术后桥管血流状态。     

THE LIMA SUCCESS STORY — WHITHER OTHER ARTERIAL GRAFTS — ARE VEIN GRAFTS OBSOLETE ?

SUMMARY The long-term benefit of myocardial revascularisation depends largely upon the continued patency of bypass grafts, but the long-term patency of vein grafts is poor. To improve the results of myocardial revascularisation, either measures to increase the patency of saphenous vein grafts or alternative conduits are required. Use of the left internal mammary artery as a graft is known to increase survival, and this has prompted wider use of other arterial grafts in the expectation that they will further enhance the long-term results of coronary artery bypass. This policy is based upon sound theory, but convincing evidence that it improves survival is lacking. Meanwhile, advances in the understanding of the pathology of vein graft occlusion have given rise to new methods of increasing vein graft patency. While these techniques are, as yet, only experimental, if translated into clinical practice, the places of arterial and venous grafts may require further assessment.     

Off-pump strategy in high-risk coronary artery bypass reoperations

OBJECTIVE: To determine the role of off-pump coronary artery bypass grafting in the treatment of patients with severe recurrent angina after coronary artery bypass grafting who are not suitable for percutaneous coronary intervention and are considered too high risk for conventional on-pump revascularization. PATIENTS AND METHODS: All patients who needed single- or double-vessel revascularization at reoperation with a predicted operative mortality of 10% or higher between March 4, 1994, and December 31, 2002, were studied. Risk stratification was performed using both the Parsonnet risk scoring system and the European System for Cardiac Operative Risk Evaluation. Active follow-up by questionnaire investigated major adverse cardiac events. RESULTS: This study consisted of 84 patients with a median age of 69 years (interquartile range, 62-75 years); 14 (17%) were female. All patients had class III/IV symptoms. Previous operations included multiple coronary artery bypass grafts (15 patients [18%]) and heart transplantation (1 patient [1%]). Internal thoracic artery graft from a previous operation was patent in 43 patients (51%). Perioperative hemodynamic support with inotropes (35%) and intra-aortic balloon pump (14%) or ventricular assist device (2%) was common. The surgical approach varied for each patient. One operative death (1%) occurred. Estimated survival at 5 and 7 years was 77% and 67%, respectively. Late major adverse cardiac events observed during follow-up were cardiac death (n=66), nonoperative reintervention (n=8), and nonfatal myocardial infarction (n=5). CONCLUSION: Off-pump coronary artery bypass grafting can mitigate reoperative risk in patients with an estimated risk of 10% or higher who are undergoing single- or double-vessel revascularization with satisfactory long-term outcome.     

Left main coronary artery rotational atherectomy and stenting

BACKGROUND: Coronary artery bypass surgery is a difficult option in patients who are not candidates for bypass surgery and high-risk patients with critical left main coronary artery (LMCA) disease. We report outcomes and short-term follow-up of patients who had LMCA rotational atherectomy and/or stenting, assess the role of these interventions in protected and unprotected significant LMCA stenosis, and review the literature. METHODS: We reviewed the cases of seven men with critical LMCA stenosis for whom coronary artery bypass surgery was considered a high risk. Five patients had rotational atherectomy, one had coronary artery stenting, and one had both. RESULTS: In all cases, angiographic success was achieved, and symptoms were relieved. Six patients were discharged from the hospital in 3 to 6 days. One patient who had cardiogenic shock, respiratory failure, and acute renal failure before the procedure died of arrhythmia 4 days afterward. Another patient had elective coronary artery bypass graft surgery 3 weeks later for recurrent angina. Cardiac catheterization was repeated in 1 month for chest pain in three patients at 4 to 7 months follow-up, and none had progression of residual stenosis in the LMCA. CONCLUSIONS: Our study suggests that LMCA rotational atherectomy and stenting are safe and effective revascularization procedures in high-risk patients and patients who are not candidates for bypass surgery.     

Intraoperative assessment of coronary grafts by novel digital epivascular imaging.

OBJECTIVE: We sought to validate and evaluate 2 novel intraoperative ultrasound probes for epicoronary and epiaortic imaging. BACKGROUND: The noninvasive intraoperative assessment of successful coronary artery bypass grafting remains a challenge. METHODS: A total of 19 consecutive patients (4 female, 15 male; mean age 60.5 +/- 13.8 years SD, range 34-84) underwent coronary artery bypass grafting. The epivascular probes (GE Ultrasound) were validated in vitro and intraoperatively. Coronary arteries, grafts, and ascending aorta were imaged and quantified. RESULTS: Mean adjusted flow measured by flowmeter was 3.25 L, SE 0.47 (range: 1-5.5 L) and was 3.15 L, SE 0.46 (range: 1-5.0 L) by ultrasound, with r = 0.97, P <.0001. Intraoperatively, 56 native coronary vessels were bypassed using 15 left internal mammary artery grafts, 25 vein grafts, and 16 venous jump grafts. A total of 15 left internal mammary artery grafts (100%), 12 left internal mammary artery anastomoses (80%), 20 vein grafts (15 left anterior descending coronary arteries, left circumflex artery grafts, 5 right coronary artery grafts) (80%), 4 jump grafts (25%), and 15 ascending aortas (78%) were successfully imaged by inexperienced surgeons. Doppler flow measurements were possible in 50 vessels (89%). Mean lumen diameter for graft arteries (veins) was 2 mm (2.87 mm), maximal velocity was 72 cm/s (46 cm/s), and mean velocity was 29 cm/s (21 cm/s) with a mean flow rate of 70 mL/m (55 mL/m). CONCLUSIONS: We conclude that: (1) the novel intraoperative probes measure validated flow; (2) intraoperative hemodynamic assessment of graft patency is feasible without a learning curve; and (3) these findings should encourage the routine use of these intraoperative epivascular digital ultrasound probes.     

Effect of antegrade graft cardioplegia combined with passive graft perfusion in on-pump coronary artery bypass grafting

Patients undergoing on-pump coronary artery bypass graft (CABG) with proximal graft anastomosis were randomly divided into groups that received antegrade cardioplegic infusion only via the aortic root (group A) or antegrade cardioplegic infusion via the aortic root and additional cardioplegia via vein or free arterial grafts after completion of each distal anastomosis (group B). The group B patients also received bypass graft perfusion with warm arterial blood just after removal of the cross-clamp until the proximal graft anastomosis was completed. The need for defibrillation and inotropic support during separation from cardiopulmonary bypass (CPB), and total CPB time were significantly lower in group B than in group A. Group B also had significantly lower peak cardiac troponin I levels 12 h after operation compared with group A and this was more pronounced in subgroups with severe right coronary artery stenosis and poor left ventricular ejection fraction than in the whole population. It is concluded that antegrade graft cardioplegia and graft perfusion with warm blood during proximal graft anastomosis may improve myocardial protection.